Description
Within our decade, a brilliant mind such as Dr. Lawrence Williams have contributed significantly to the medical field. Dr. Williams was born in St. Elizabeth Jamaica. Dr. Williams obtained his PhD from the University of West Indies. In 2003, Dr. Lawrence was awarded the prominent award known as the Alexander Von Hombolt scholarship. Thereafter, he carried on post-doctoral studies to research on the "guinea hen weed". Dr. Williams along with his colleague Dr. H.G. Levi ushered in ground-breaking treatments to the world that have shown effective results against 12 different forms of cancer. The groundbreaking treatment has the capability to arrest "two to three types of breast cancer," neuroblastoma, lung, metranoma, adenocarcionoma, including prostrate, etc.
In 2010, Dr. William, and his co-researcher Dr. H G. Levy were awarded an international patent for the complex protein dibenzyl trisulphide (DTS) . Ultimately, through their medical research, Dr. Lawrence's and his colleague isolated the compound dibenzyl trisulphide (DTS) that is capable of arresting cells that affect the bladder, breast, brain, skin, including lungs. Their research yielded result for the creation of an alternative forms of treatment to combat cancer. In 2017, Dr. Lawrence and Dr. Levy were awarded a patent for the discovery of treatments for the anti-cancer activity found in guinea hen weed. the United States Patent Office
Dr. Lawrence is an extraordinary Physician and consultant to the Scientific Research Council within Jamaica. Professors Harold Rosner and Wolfgang Kraus were also instrumental to assist in research. Dr. Lawrence and Dr. Levy have brought to the market one of the most exciting medical breakthroughs of our time.
In 2010, Dr. Williams and his partner, Dr. H.G. Levy, a Jamaican-born medical doctor were both awarded an international patent on the protein complex known as dibenzyl trisulphide for the isolation of the “guinea hen weed”.
Historical Data on the performance of a medical company or cutting edge technology coming out of Ghana, Ethiopia, South Africa, Tanzania, Zambia in Africa including the Caribbean for a country such as Jamaica will give you the ability to help make decisions.
By the year 2025, it is estimated that Africa will host 20% of the world’s population, according to McKinsey & Company. By 2017, capital flows increased within emerging markets up to $141 billion. During 2017, institutional fund managers invested up to $2.5 million in equities in to the continent of Africa.
Dr. Lawrence company groundbreaking treatment has the capability to penetrate six emerging markets in African with upstream growth potential in sub-Sahara to exceed 300 million African households by the turn of the decade.
